MedTrace Logo

Air Optix Daily Wear Contact Lenses

NCT05827224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 312

Last updated 2024-08-15

No results posted yet for this study

Summary

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as daily wear.

Conditions

  • Refractive Errors

Interventions

DEVICE

Lotrafilcon B spherical soft contact lenses

Commercially available silicone hydrogel contact lenses

DEVICE

Lotrafilcon B spherical soft contact lenses with comfort additive

Commercially available silicone hydrogel contact lenses

DEVICE

Lotrafilcon B toric soft contact lenses with comfort additive

Commercially available silicone hydrogel contact lenses

DEVICE

Comfilcon A spherical soft contact lenses

Commercially available silicone hydrogel contact lenses

DEVICE

Comfilcon A toric soft contact lenses

Commercially available silicone hydrogel contact lenses

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Vision Care · Alcon Research, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-02
Primary Completion
2024-07-17
Completion
2024-07-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827224 on ClinicalTrials.gov